23
Participants
Start Date
March 15, 2008
Primary Completion Date
May 1, 2009
Study Completion Date
May 15, 2009
LGD-4665
LGD-4665 Thrombopoietin mimetic
Placebo
Placebo
Joan and Sanford I. Weill Medical College, Cornell University, New York
Mount Sinai School of Medicine, New York
Georgia Cancer Specialists, Atlanta
Baptist Cancer Institute, Jacksonville
Cancer Center of Florida, Orlando
Cleveland Clinic Foundation, Univ. of Ohio, Cleveland
Karmanos Cancer Center, Wertz Clinical Cancer Center 4HWCRC, Detroit
Henry Ford Health System, Detroit
Washington University School of Medicine - St Louis, MO, St Louis
Hematology Oncology Associates of South Texas, San Antonio
New Mexico Oncology Hematology Consultants, Albuquerque
University of California San Diego Medical Center, San Diego
University of California, San Francisco, San Francisco
Davis, Posteraro and Wasser, MD's LLP, Manchester
Case Western Reserve University School of Medicine, Cleveland
Lead Sponsor
GlaxoSmithKline
INDUSTRY